IL6 and head and neck cancer: Collectively, these results demonstrate that endothelial cell-secreted IL-6 induces a migratory phenotype in head and neck cancer stem cells and suggest that the progression of HNSCC towards metastasis or recurrence might be prevented or delayed by therapeutic blockage of the IL-6 pathway.